tiprankstipranks
AB Science SA (ABSCF)
OTHER OTC:ABSCF

AB Science SA (ABSCF) Stock Price & Analysis

14 Followers

ABSCF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.55 - $9.00
Previous Close$2.7
Volume1.45K
Average Volume (3M)39.95K
Market Cap
$141.71M
Enterprise Value$151.14M
Total Cash (Recent Filing)€7.64M
Total Debt (Recent Filing)€16.36M
Price to Earnings (P/E)-7.2
Beta-123602.13
Apr 30, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.38
Shares Outstanding51,071,069
10 Day Avg. Volume8,080
30 Day Avg. Volume39,951
Standard Deviation0.31
R-Squared0.02
Alpha0.00330
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.02%0.07%99.91%
0.00%
Insiders
0.07% Other Institutional Investors
99.91% Public Companies and
Individual Investors

ABSCF FAQ

What was AB Science SA’s price range in the past 12 months?
AB Science SA lowest stock price was $2.55 and its highest was $9.00 in the past 12 months.
    What is AB Science SA’s market cap?
    Currently, no data Available
    When is AB Science SA’s upcoming earnings report date?
    AB Science SA’s upcoming earnings report date is Apr 30, 2024 which is in 32 days.
      How were AB Science SA’s earnings last quarter?
      AB Science SA released its earnings results on Sep 29, 2023. The company reported -$0.237 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.237.
        Is AB Science SA overvalued?
        According to Wall Street analysts AB Science SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does AB Science SA pay dividends?
          AB Science SA does not currently pay dividends.
          What is AB Science SA’s EPS estimate?
          AB Science SA’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does AB Science SA have?
          AB Science SA has 51,071,068 shares outstanding.
            What happened to AB Science SA’s price movement after its last earnings report?
            AB Science SA reported an EPS of -$0.237 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of AB Science SA?
              Currently, no hedge funds are holding shares in ABSCF
              ---

              AB Science SA Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              20 days / 200 days
              Momentum
              -70.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              60.50%
              Trailing 12-Months

              Company Description

              AB Science SA

              AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Arca Biopharma
              Abeona Therapeutics
              Abbott Labs
              ACADIA Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis